Whitnell & Co’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$84K Hold
742
0.03% 184
2019
Q3
$81K Sell
742
-141
-16% -$14.7K 0.03% 184
2019
Q2
$86K Hold
883
0.03% 170
2019
Q1
$80K Hold
883
0.03% 171
2018
Q4
$80K Hold
883
0.04% 167
2018
Q3
$87K Hold
883
0.03% 164
2018
Q2
$76K Hold
883
0.03% 164
2018
Q1
$71K Buy
883
+448
+103% +$37K 0.03% 170
2017
Q4
$35K Sell
435
-445
-51% -$35.6K 0.01% 183
2017
Q3
$68K Buy
+880
New +$73.1K 0.03% 167
2017
Q2
Sell
-61
Closed -$5K 246
2017
Q1
$5K Buy
+61
New +$4.76K ﹤0.01% 245
2015
Q2
Sell
-47
Closed -$4K 257
2015
Q1
$4K Buy
+47
New +$3.56K ﹤0.01% 246
2013
Q4
Sell
-1,100
Closed -$59K 268
2013
Q3
$59K Hold
1,100
0.03% 178
2013
Q2
$57K Buy
+1,100
New +$54.4K 0.03% 184

Other funds holding MDT

Whitnell & Co's MDT Position: Q4 2019 in Review

Whitnell & Co held its Medtronic (MDT) position steady in Q4 2019 at 742 shares worth $84K. The position accounts for 0.03% of the portfolio, ranked #184.

Whitnell & Co first reported a position in MDT in Q2 2013 and has held it in 14 quarters since. The position peaked at $87K in Q3 2018. 1,820 funds tracked by Wall St. Rank hold MDT as of Q4 2019.

  • Whitnell & Co held 742 shares of Medtronic worth $84K as of Q4 2019.
  • Whitnell & Co left its Medtronic share count unchanged in Q4 2019.
  • Medtronic made up 0.03% of Whitnell & Co's portfolio in Q4 2019, its #184 holding.
  • Whitnell & Co first reported a position in Medtronic in Q2 2013 and has held it in 14 quarters since.
  • Whitnell & Co's Medtronic position peaked at $87K in Q3 2018.
  • 1,820 funds tracked by Wall St. Rank held Medtronic as of Q4 2019.

Based on Whitnell & Co's 13F filing for Q4 2019, filed 11 Feb 2020.